{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:10:35Z","timestamp":1790719835566,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.medcli.2026.107638","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:37:08Z","timestamp":1790717828000},"page":"107638","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum KL-6 as a diagnostic and prognostic biomarker in inflammatory myopathies-associated interstitial lung disease: A single-centre prospective cohort study"],"prefix":"10.1016","volume":"166","author":[{"given":"Jorge","family":"\u00c1lvarez-Troncoso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"D\u00edaz-Planellas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"G\u00f3mez-Carrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Fern\u00e1ndez-Velilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Soto-Ab\u00e1nades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Mart\u00ednez-Robles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jos\u00e9","family":"R\u00edos-Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2026.107638_bib0145","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41572-021-00321-x","article-title":"Idiopathic inflammatory myopathies","volume":"7","author":"Lundberg","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.medcli.2026.107638_bib0150","doi-asserted-by":"crossref","first-page":"322","DOI":"10.7861\/clinmedicine.17-4-322","article-title":"Idiopathic inflammatory myopathies\u2014a guide to subtypes, diagnostic approach and treatment","volume":"17","author":"Oldroyd","year":"2017","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.medcli.2026.107638_bib0155","doi-asserted-by":"crossref","first-page":"e70295","DOI":"10.1111\/1756-185X.70295","article-title":"Classification in idiopathic inflammatory myopathies: where are we now?","volume":"28","author":"Shivakumar","year":"2025","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.medcli.2026.107638_bib0160","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.medcli.2026.107638_bib0165","doi-asserted-by":"crossref","first-page":"1096203","DOI":"10.3389\/fmed.2022.1096203","article-title":"Clinical features and outcomes of patients with myositis associated-interstitial lung disease","volume":"9","author":"Karampitsakos","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.medcli.2026.107638_bib0170","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12016-020-08814-5","article-title":"Predictive features and clinical presentation of interstitial lung disease in inflammatory myositis","volume":"60","author":"Vojinovic","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.medcli.2026.107638_bib0175","doi-asserted-by":"crossref","first-page":"1068402","DOI":"10.3389\/fmed.2023.1068402","article-title":"Interstitial lung disease associated with inflammatory myositis: autoantibodies, clinical phenotypes, and progressive fibrosis","volume":"10","author":"Ceribelli","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.medcli.2026.107638_bib0180","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3389\/fneur.2019.00554","article-title":"Biomarkers in inflammatory myopathies\u2014an expanded definition","volume":"10","author":"Benveniste","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.medcli.2026.107638_bib0185","doi-asserted-by":"crossref","first-page":"2101499","DOI":"10.1183\/13993003.01499-2021","article-title":"ERS\/ATS technical standard on interpretive strategies for routine lung function tests","volume":"60","author":"Stanojevic","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.medcli.2026.107638_bib0190","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s40674-025-00237-7","article-title":"The impact of autoantibody profiles on treatment response in idiopathic inflammatory myopathies","volume":"11","author":"\u00c1lvarez-Troncoso","year":"2025","journal-title":"Curr Treat Options Rheumatol"},{"key":"10.1016\/j.medcli.2026.107638_bib0195","doi-asserted-by":"crossref","first-page":"e19493","DOI":"10.1097\/MD.0000000000019493","article-title":"Diagnostic and prognostic predictive values of circulating KL-6 for interstitial lung disease: a PRISMA-compliant systematic review and meta-analysis","volume":"99","author":"Zhang","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.medcli.2026.107638_bib0200","doi-asserted-by":"crossref","first-page":"e0244114","DOI":"10.1371\/journal.pone.0244114","article-title":"Serum Krebs von den Lungen-6 level predicts disease progression in interstitial lung disease","volume":"15","author":"Ko","year":"2020","journal-title":"PLOS ONE"},{"key":"10.1016\/j.medcli.2026.107638_bib0205","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13075-019-1835-9","article-title":"Serum KL-6 levels reflect the severity of interstitial lung disease associated with connective tissue disease","volume":"21","author":"Lee","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.medcli.2026.107638_bib0210","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1186\/s12890-024-03264-7","article-title":"Evaluating the diagnostic and prognostic utility of serial KL-6 measurements in connective tissue disease patients at risk for interstitial lung disease: correlations with pulmonary function tests and high-resolution computed tomography","volume":"24","author":"\u00c1lvarez-Troncoso","year":"2024","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.medcli.2026.107638_bib0215","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.745233","article-title":"KL-6 as an immunological biomarker predicts the severity, progression, acute exacerbation, and poor outcomes of interstitial lung disease: a systematic review and meta-analysis","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"issue":"suppl 1","key":"10.1016\/j.medcli.2026.107638_bib0220","first-page":"141","article-title":"Biomarkers and autoantibodies of interstitial lung disease with idiopathic inflammatory myopathies","volume":"9","author":"Yoshifuji","year":"2016","journal-title":"Clin Med Insights Circ Respir Pulm Med"},{"key":"10.1016\/j.medcli.2026.107638_bib0225","doi-asserted-by":"crossref","first-page":"e19695","DOI":"10.1097\/MD.0000000000019695","article-title":"Comparative diagnostic efficacy of serum Krebs von den Lungen-6 and surfactant D for connective tissue disease-associated interstitial lung diseases: a meta-analysis","volume":"99","author":"Zhong","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.medcli.2026.107638_bib0230","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.arbres.2024.03.028","article-title":"Diagnostic value of Krebs von den Lungen (KL-6) for interstitial lung disease: a European prospective cohort","volume":"60","author":"Millan-Billi","year":"2024","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.medcli.2026.107638_bib0235","doi-asserted-by":"crossref","first-page":"e003121","DOI":"10.1136\/rmdopen-2023-003121","article-title":"Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort","volume":"9","author":"Zanatta","year":"2023","journal-title":"RMD Open"},{"key":"10.1016\/j.medcli.2026.107638_bib0240","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3390\/jcm12031173","article-title":"Serum KL-6 as a biomarker of progression at any time in fibrotic interstitial lung disease","volume":"12","author":"Jehn","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.medcli.2026.107638_bib0245","doi-asserted-by":"crossref","first-page":"35243","DOI":"10.1038\/s41598-025-22483-4","article-title":"Serum KL-6 as a biomarker to predict progression at one year in interstitial lung disease","volume":"15","author":"Bonella","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.medcli.2026.107638_bib0250","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.21037\/jtd.2018.07.76","article-title":"Sequential changes of serum KL-6 predict the progression of interstitial lung disease","volume":"10","author":"Jiang","year":"2018","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.medcli.2026.107638_bib0255","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.medcli.2026.107638_bib0260","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.medcli.2026.107638_bib0265","doi-asserted-by":"crossref","first-page":"180076","DOI":"10.1183\/16000617.0076-2018","article-title":"Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases","volume":"27","author":"Cottin","year":"2018","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.medcli.2026.107638_bib0270","doi-asserted-by":"crossref","first-page":"180100","DOI":"10.1183\/16000617.0100-2018","article-title":"Fibrosing interstitial lung diseases: knowns and unknowns","volume":"28","author":"Cottin","year":"2019","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.medcli.2026.107638_bib0275","article-title":"KL-6 levels in the connective tissue disease population: typical values and potential confounders\u2014a retrospective, real-world study","volume":"14","author":"Zhou","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.medcli.2026.107638_bib0280","doi-asserted-by":"crossref","first-page":"152366","DOI":"10.1016\/j.semarthrit.2024.152366","article-title":"KL-6 and IL-18 levels are negatively correlated with respiratory function tests and ILD extent assessed on HRCT in patients with systemic sclerosis-related interstitial lung disease (SSc-ILD)","volume":"65","author":"Sieiro-Santos","year":"2024","journal-title":"Semin Arthritis Rheum"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775326002897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775326002897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:37:18Z","timestamp":1790717838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775326002897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0025775326002897"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2026.107638","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum KL-6 as a diagnostic and prognostic biomarker in inflammatory myopathies-associated interstitial lung disease: A single-centre prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2026.107638","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107638"}}